Open AccessManagement of patients with long QT syndrome
Author(s) -
Cay Serkan,
Ozeke Ozcan,
Ozcan Firat,
Koca Serhat,
Pac Aysenur,
Aras Dursun,
Topaloglu Serkan
Publication year - 2017
Publication title -
journal of arrhythmia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 21
eISSN - 1883-2148
pISSN - 1880-4276
DOI - 10.1016/j.joa.2017.07.002
Subject(s) - medicine , nadolol , cardiology , implantable cardioverter defibrillator , long qt syndrome , qt interval , propranolol
I have read with great interest the case report entitled “Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome” by Sugiyama et al. in the latest issue of the journal [1]. The authors well presented a case of long QT syndrome managed using implantation of an epicardial shock electrode and dose titration of beta-blocker therapy. However, some important issues should be mentioned. As compared to beta-blocker therapy with metoprolol, treatment with nadolol has been shown to significantly decrease breakthrough cardiac events in symptomatic patients [2]. Furthermore,